Healthcare and Life Science
Keytruda LoE: A seismic shift for oncology?
Immune checkpoint inhibitors (ICIs) have changed the face of oncology treatment since their initial entry in the early 2010s. Driven mostly by the group of PD-1 and PD-L1 molecules, they have resulted in cumulative 2023 global revenues exceeding $45 billion USD. Within the PD-...
Cambridge Psychosis Centre offers specialist advice for complex cases
CPFT experts have launched a new service providing specialist advice and guidance with research to help people living with severe mental health conditions schizophrenia and psychosis. ...
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
AstraZeneca announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs contributing to the g...
Illumina Community Fund launches to support cancer patients and their loved ones
Grants of up to £10,000 are available for charity and community projects in Cambridgeshire benefitting individuals diagnosed with cancer and their loved ones. ...
Claire Nicholls joins Salus Wellness Clinics
We are excited to welcome Claire Nicholls to Salus Wellness this month.
Parkwalk and Cambridge Enterprise launch tenth University of Cambridge Enterprise Fund
Cambridge, November 2024 - Parkwalk Advisors, in collaboration with Cambridge Enterprise, is proud to announce the launch of the University of Cambridge Enterprise Fund X (UCEF X). ...
Bio-Rad demonstrates leadership position in the oncology market at Association for Molecular Pathology 2024
Strength of ddPCR™ Products, Including IVDR Certification, Strategic Collaborations in Molecular Residual Disease Monitoring, and Large Methylation Assay Library, Support Company’s Oncology Strategy ...
Mursla Bio joins leading European consortium to advance clinical applications based on extracellular vesicle science
Selected to support scaling and commercialization strategy for extracellular vesicle-based disease surveillance and diagnostics Consortium funded by Horizon Europe, the largest European research and innovation program Cambridge, UK, and Boston, MA, USA: Mursla Bio, a leader in Extr...
The Crown Estate to breathe new life into Cambridge Business Park as it unveils bold proposals to support the UK’s science, innovation, and technology ambitions
Cambridge Business Park is set to contribute to a new innovation ecosystem in Northeast Cambridge, providing a variety of office and lab spaces for start-ups and established businesses, alongside a residential, leisure and cultural offer for the wider community. It will greatly support ...
The Epicentre launches a new growth accelerator programme to help its occupiers build for their future
The Epicentre at Haverhill has launched a growth accelerator programme to help its clients’ growth with two unique options to suit startups, R&D spinouts, and established SMEs ...